Illumina Receives FDA 510(k) Clearance for its BeadXpress® Multiplex Analysis System
News May 04, 2010
Illumina, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for the company's BeadXpress system for multiplex genetic analysis.
According to the FDA's indications of use, the BeadXpress system - consisting of Illumina's BeadXpress Reader and VeraScan software - is an in-vitro diagnostic device intended for the simultaneous detection of multiple analytes in a DNA sample utilizing VeraCode holographic microbead technology.
"This approval represents a significant and exciting transitional step for Illumina into the diagnostics field, where the potential is great for molecular medicine to make a real difference in the way disease is detected and ultimately prevented and treated," said Jay Flatley, president and CEO.
He continues, "It demonstrates Illumina's ability to meet stringent regulatory requirements in designing and manufacturing an FDA-cleared in-vitro diagnostic device. This will serve as an important foundation for our future plans in the diagnostics area. Ultimately, our goal is to become a leader in translational medicine, focusing on complex diseases that benefit from high performance analysis, including genotyping, copy number, gene expression, methylation and protein analysis."
Illumina introduced the BeadXpress system in 2007 with Research Use Only kits for custom genotyping, gene expression, methylation and protein analysis. Since then it has been adopted by research, agricultural, industrial and pharmaceutical institutions worldwide.
Breakthrough Leads to New Research Into Cancer Treatment for ChildrenNews
The new form of treatment is based on the protein molecule named CD40, which destroys cancerous tumours without harming healthy cell tissue.READ MORE
Gene Associated with Schizophrenia Risk May Regulate NeurodevelopmentNews
The gene is involved in the translation of proteins from RNA and in the proliferation and migration of neurons in the brain.READ MORE
Regenerating Tissues with Gene-targeting MoleculesNews
Stem cells can be triggered to change into heart muscle cells by a new method involving synthetic molecules.READ MORE